There is also growing interest in applying NIBS in pre-symptomatic individuals carrying ALS-associated mutations with high penetrance, such as SOD1, FUS, TARDBP, and C9orf72. The gene discussed is C9orf72; the disease is amyotrophic lateral sclerosis.